Signal transduction by wild-type and leukemogenic Abl proteins
- 10 December 1997
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1333 (3) , F201-F216
- https://doi.org/10.1016/s0304-419x(97)00023-1
Abstract
No abstract availableThis publication has 142 references indexed in Scilit:
- Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformationCancer Genetics and Cytogenetics, 1995
- Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinasesCurrent Biology, 1995
- P53 Tumor suppressor gene in chronic myelogenous leukemia: A sequential studyAnnals of Hematology, 1995
- Direct demonstration of an intramolecular SH2—phosphotyrosine interaction in the Crk proteinNature, 1995
- A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycleCell, 1993
- The BCR gene encodes a novel serine/threonine kinase activity within a single exonCell, 1991
- BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent mannerCell, 1991
- Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populationsCell, 1991
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogeneCell, 1991
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988